Hanway teams up with Savills and CambridgeHOK to help British farmers, food companies and landowners capitalise on medical cannabis opportunities.

We were very proud to bring Cannabis Europa back to London this June.

How will European CBD businesses be affected? Recent to the European Union’s Novel Foods Catalogue have occurred regarding the use of cannabidiol (CBD), other cannabinoids and hemp-derived products in food.

The past six months have seen an unprecedented rate of change for both the global and European cannabis industry. Today, for the first time, patients across the United Kingdom will be able to be prescribed a range of cannabis-based medicinal products.

The UK government has laid historic new regulations rescheduling cannabis-based medicine, which will come into force on 1st November 2018.

On September 21st the UK government announced how they would define cannabis-based products for medicinal use. Following the conclusion of the two part review by the Chief Medical Officer and the ACMD on July 25th, Home Secretary Sajid Javid committed to swift action on the matter, and promised that these products would be lawful by autumn.

This is the first in a blog series profiling exciting companies, projects and people who are paving the way in the UK cannabis space. Separating The Strains is a documentary, currently in production, that explores medical cannabis treatments for epilepsy patients and others. 

January 1st was a momentous day for the cannabis industry and drug policy reform globally. A week ago, when the clock struck midnight, California began legal sales of cannabis for adult use.

Despite cannabis being the most used illicit drug in the UK, little is known about the true scale of the UK cannabis market.